These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 18687662)

  • 1. Differential effects of arginine methylation on diastolic dysfunction and disease progression in patients with chronic systolic heart failure.
    Tang WH; Tong W; Shrestha K; Wang Z; Levison BS; Delfraino B; Hu B; Troughton RW; Klein AL; Hazen SL
    Eur Heart J; 2008 Oct; 29(20):2506-13. PubMed ID: 18687662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitric oxide bioavailability and adiponectin production in chronic systolic heart failure: relation to severity of cardiac dysfunction.
    Tang WH; Shrestha K; Tong W; Wang Z; Troughton RW; Borowski AG; Klein AL; Hazen SL
    Transl Res; 2013 Jul; 162(1):26-33. PubMed ID: 23499315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted metabolomic evaluation of arginine methylation and cardiovascular risks: potential mechanisms beyond nitric oxide synthase inhibition.
    Wang Z; Tang WH; Cho L; Brennan DM; Hazen SL
    Arterioscler Thromb Vasc Biol; 2009 Sep; 29(9):1383-91. PubMed ID: 19542023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary hypertension associated with advanced systolic heart failure: dysregulated arginine metabolism and importance of compensatory dimethylarginine dimethylaminohydrolase-1.
    Shao Z; Wang Z; Shrestha K; Thakur A; Borowski AG; Sweet W; Thomas JD; Moravec CS; Hazen SL; Tang WH
    J Am Coll Cardiol; 2012 Mar; 59(13):1150-8. PubMed ID: 22440215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Right atrial volume index in chronic systolic heart failure and prognosis.
    Sallach JA; Tang WH; Borowski AG; Tong W; Porter T; Martin MG; Jasper SE; Shrestha K; Troughton RW; Klein AL
    JACC Cardiovasc Imaging; 2009 May; 2(5):527-34. PubMed ID: 19442936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incremental prognostic value of assessing left ventricular myocardial mechanics in patients with chronic systolic heart failure.
    Motoki H; Borowski AG; Shrestha K; Troughton RW; Tang WH; Thomas JD; Klein AL
    J Am Coll Cardiol; 2012 Nov; 60(20):2074-81. PubMed ID: 23083779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic profiling of arginine and nitric oxide pathways predicts hemodynamic abnormalities and mortality in patients with cardiogenic shock after acute myocardial infarction.
    Nicholls SJ; Wang Z; Koeth R; Levison B; DelFraino B; Dzavik V; Griffith OW; Hathaway D; Panza JA; Nissen SE; Hochman JS; Hazen SL
    Circulation; 2007 Nov; 116(20):2315-24. PubMed ID: 17967979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA) and homoarginine (hArg): the ADMA, SDMA and hArg paradoxes.
    Tsikas D; Bollenbach A; Hanff E; Kayacelebi AA
    Cardiovasc Diabetol; 2018 Jan; 17(1):1. PubMed ID: 29301528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Symmetric dimethylarginine (SDMA) outperforms asymmetric dimethylarginine (ADMA) and other methylarginines as predictor of renal and cardiovascular outcome in non-dialysis chronic kidney disease.
    Emrich IE; Zawada AM; Martens-Lobenhoffer J; Fliser D; Wagenpfeil S; Heine GH; Bode-Böger SM
    Clin Res Cardiol; 2018 Mar; 107(3):201-213. PubMed ID: 29101459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma concentrations of arginine and asymmetric dimethylarginine do not reflect their intracellular concentrations in peripheral blood mononuclear cells.
    Davids M; Teerlink T
    Metabolism; 2013 Oct; 62(10):1455-61. PubMed ID: 23890667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Asymmetric Dimethylarginine Predicts Long-Term Outcome in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
    Vögeli A; Ottiger M; Meier MA; Steuer C; Bernasconi L; Huber A; Christ-Crain M; Henzen C; Hoess C; Thomann R; Zimmerli W; Mueller B; Schuetz P
    Lung; 2017 Dec; 195(6):717-727. PubMed ID: 28852826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylarginines and mortality in patients with end stage renal disease: a prospective cohort study.
    Aucella F; Maas R; Vigilante M; Tripepi G; Schwedhelm E; Margaglione M; Gesualdo L; Boeger R; Zoccali C
    Atherosclerosis; 2009 Dec; 207(2):541-5. PubMed ID: 19501358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations of methylarginines and homoarginine with diastolic dysfunction and cardiovascular risk factors in patients with preserved left ventricular ejection fraction.
    Pilz S; Edelmann F; Meinitzer A; Gelbrich G; Döner U; Düngen HD; Tomaschitz A; Kienreich K; Gaksch M; Duvinage A; Stahrenberg R; Kunde J; Schmidt A; März W; Wachter R; Pieske B
    J Card Fail; 2014 Dec; 20(12):923-30. PubMed ID: 25230239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From arginine methylation to ADMA: a novel mechanism with therapeutic potential in chronic lung diseases.
    Zakrzewicz D; Eickelberg O
    BMC Pulm Med; 2009 Jan; 9():5. PubMed ID: 19178698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intestinal microbiota-dependent phosphatidylcholine metabolites, diastolic dysfunction, and adverse clinical outcomes in chronic systolic heart failure.
    Tang WH; Wang Z; Shrestha K; Borowski AG; Wu Y; Troughton RW; Klein AL; Hazen SL
    J Card Fail; 2015 Feb; 21(2):91-6. PubMed ID: 25459686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ADMA, subclinical changes and atrial fibrillation in the general population.
    Ramuschkat M; Appelbaum S; Atzler D; Zeller T; Bauer C; Ojeda FM; Sinning CR; Hoffmann B; Lackner KJ; Böger RH; Wild PS; Münzel T; Blankenberg S; Schwedhelm E; Schnabel RB;
    Int J Cardiol; 2016 Jan; 203():640-6. PubMed ID: 26580348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical aspects of left ventricular diastolic function assessed by Doppler echocardiography following acute myocardial infarction.
    Poulsen SH
    Dan Med Bull; 2001 Nov; 48(4):199-210. PubMed ID: 11767125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Admission levels of asymmetric and symmetric dimethylarginine predict long-term outcome in patients with community-acquired pneumonia.
    Vögeli A; Ottiger M; Meier MA; Steuer C; Bernasconi L; Kulkarni P; Huber A; Christ-Crain M; Henzen C; Hoess C; Thomann R; Zimmerli W; Mueller B; Schuetz P
    Respir Res; 2017 Jan; 18(1):25. PubMed ID: 28114935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating levels of dimethylarginines, chronic kidney disease and long-term clinical outcome in non-ST-elevation myocardial infarction.
    Cavalca V; Veglia F; Squellerio I; De Metrio M; Rubino M; Porro B; Moltrasio M; Tremoli E; Marenzi G
    PLoS One; 2012; 7(11):e48499. PubMed ID: 23185262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asymmetric and Symmetric Dimethylarginine Predict Outcomes in Patients With Atrial Fibrillation: An ARISTOTLE Substudy.
    Horowitz JD; De Caterina R; Heresztyn T; Alexander JH; Andersson U; Lopes RD; Steg PG; Hylek EM; Mohan P; Hanna M; Jansky P; Granger CB; Wallentin L;
    J Am Coll Cardiol; 2018 Aug; 72(7):721-733. PubMed ID: 30092948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.